Effects of COVID-19 lockdown strategies on management of atrial fibrillation.
作者信息
Blomström-Lundqvist Carina
机构信息
Department of Medical Science and Cardiology, Uppsala University, S-75185 Uppsala, Sweden.
出版信息
Eur Heart J. 2020 Sep 1;41(32):3080-3082. doi: 10.1093/eurheartj/ehaa538.
Abstract
摘要
相似文献
1
Effects of COVID-19 lockdown strategies on management of atrial fibrillation.2019冠状病毒病封锁策略对心房颤动管理的影响。
Eur Heart J. 2020 Sep 1;41(32):3080-3082. doi: 10.1093/eurheartj/ehaa538.
2
Atrial Arrhythmias in a Patient Presenting With Coronavirus Disease-2019 (COVID-19) Infection.一名新型冠状病毒肺炎（COVID-19）感染患者的房性心律失常
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620925571. doi: 10.1177/2324709620925571.
3
Lockdown-type measures look effective against covid-19.封锁类措施看起来对新冠病毒有效。
BMJ. 2020 Jul 15;370:m2809. doi: 10.1136/bmj.m2809.
4
Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk?新冠疫情时代的心房颤动：单纯的旁观者还是风险增加的标志物？
Eur Heart J. 2020 Jul 1;41(32):3094. doi: 10.1093/eurheartj/ehaa576.
5
Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?心房颤动是否应被视为COVID-19患者预后较差的心血管危险因素？
Eur Heart J. 2020 Jul 1;41(32):3092-3093. doi: 10.1093/eurheartj/ehaa509.
6
TeleCheck-AF for COVID-19.用于新冠肺炎的TeleCheck-AF
Eur Heart J. 2020 Jun 1;41(21):1954-1955. doi: 10.1093/eurheartj/ehaa404.
7
Choosing Wisely: Cardiovascular Drug Therapy in the Era of COVID-19.明智选择：新冠疫情时代的心血管药物治疗
J Cardiovasc Pharmacol. 2020 Aug;76(2):123-124. doi: 10.1097/FJC.0000000000000875.
8
New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people.新发心房颤动：在全国 560 万人的 COVID-19 封锁后，发病率、特征和相关事件。
Eur Heart J. 2020 Jun 1;41(32):3072-3079. doi: 10.1093/eurheartj/ehaa494.
9
New data on soluble ACE2 in patients with atrial fibrillation reveal potential value for treatment of patients with COVID-19 and cardiovascular disease.心房颤动患者可溶性血管紧张素转换酶2的新数据揭示了其在治疗新冠病毒肺炎和心血管疾病患者中的潜在价值。
Eur Heart J. 2020 Nov 1;41(41):4047-4049. doi: 10.1093/eurheartj/ehaa761.
10
The catch-22 of the COVID-19 "lockdown".新冠疫情“封锁”的第二十二条军规。
Adv Respir Med. 2020;88(3):285-286. doi: 10.5603/ARM.a2020.0097.
引用本文的文献
1
Incidence and Predictors of Clinical Outcomes in Real-Life Patients With Atrial Fibrillation Treated With Oral Factor Xa Inhibitors: The Follow-Up Results of the ANATOLIA-AF Study.口服Xa因子抑制剂治疗的心房颤动真实患者临床结局的发生率及预测因素：ANATOLIA-AF研究的随访结果
Clin Cardiol. 2025 Jan;48(1):e70088. doi: 10.1002/clc.70088.
2
Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device.使用手持式单导联心电图设备进行单时间点筛查时与房颤检测相关的临床因素
J Clin Med. 2021 Feb 12;10(4):729. doi: 10.3390/jcm10040729.
3
The Impact of the COVID-19 Pandemic on Incidences of Atrial Fibrillation and Electrical Cardioversion at a Tertiary Care Emergency Department: An Inter- and Intra-year Analysis.新冠疫情对三级医疗急诊科心房颤动发病率及电复律的影响：跨年度及年度内分析
Front Med (Lausanne). 2020 Dec 4;7:595881. doi: 10.3389/fmed.2020.595881. eCollection 2020.
4
Understanding COVID-19: in the end it is the endothelium-what else?了解新型冠状病毒肺炎：归根结底是内皮细胞的问题——还能有什么别的呢？
Eur Heart J. 2020 Aug 21;41(32):3023-3027. doi: 10.1093/eurheartj/ehaa706.
本文引用的文献
1
New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people.新发心房颤动：在全国 560 万人的 COVID-19 封锁后，发病率、特征和相关事件。
Eur Heart J. 2020 Jun 1;41(32):3072-3079. doi: 10.1093/eurheartj/ehaa494.
2
Time to treatment still matters in ST-elevation myocardial infarction: a call to maintain treatment effectiveness during the COVID-19 pandemic.在ST段抬高型心肌梗死中，治疗时间仍然至关重要：呼吁在COVID-19大流行期间维持治疗效果。
Eur Heart J Cardiovasc Pharmacother. 2020 Nov 1;6(6):408-409. doi: 10.1093/ehjcvp/pvaa054.
3
On-demand app-based rate and rhythm monitoring to manage atrial fibrillation through teleconsultations during COVID-19.在新冠疫情期间，通过远程会诊利用基于按需应用程序的心率和节律监测来管理心房颤动。
Int J Cardiol Heart Vasc. 2020 May 8;28:100533. doi: 10.1016/j.ijcha.2020.100533. eCollection 2020 Jun.
4
An In-hospital Pathway for Acute Coronary Syndrome Patients During the COVID-19 Outbreak: Initial Experience Under Real-World Suboptimal Conditions.在 COVID-19 大流行期间急性冠状动脉综合征患者的院内通路：在现实世界中条件欠佳情况下的初步经验。
Can J Cardiol. 2020 Jun;36(6):961-964. doi: 10.1016/j.cjca.2020.04.011. Epub 2020 Apr 17.
5
Impact of coronavirus disease 2019 (COVID-19) outbreak on outcome of myocardial infarction in Hong Kong, China.新型冠状病毒病 2019（COVID-19）疫情对中国香港地区心肌梗死结局的影响。
Catheter Cardiovasc Interv. 2021 Feb 1;97(2):E194-E197. doi: 10.1002/ccd.28943. Epub 2020 May 5.
6
Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic.新冠疫情期间美国ST段抬高型心肌梗死导管插入实验室激活率的降低
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872. doi: 10.1016/j.jacc.2020.04.011. Epub 2020 Apr 10.
7
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study.预测 SARS-CoV-2 引起的 COVID-19 肺炎患者死亡率的前瞻性队列研究。
Eur Respir J. 2020 May 7;55(5). doi: 10.1183/13993003.00524-2020. Print 2020 May.
8
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
9
Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action.全球远程医疗在卫生系统中的实施和整合，以抗击 COVID-19 大流行：行动呼吁。
JMIR Public Health Surveill. 2020 Apr 2;6(2):e18810. doi: 10.2196/18810.
10
A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations.新冠疫情期间中国人心理困扰的全国性调查：启示与政策建议
Gen Psychiatr. 2020 Mar 6;33(2):e100213. doi: 10.1136/gpsych-2020-100213. eCollection 2020.
Zotero 插件